EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis

Xiaogang Li, Chao Niu, Guoqiang Yi, Yuan Zhang, Wendi Jin, Zhiping Zhang, Wanfu Zhang, Bo Li iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0305612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Xiaogang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Affiliated Hospital of Yunnan University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, MicroRNAs, Breast Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Medical Reserve Talent Program of Yunnan Provincial Health Commission, Scientific Research Fund Project of Education Department of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) cells have a high risk of metastasis due to epithelial-mesenchymal transition (EMT). Palbociclib (CDK4/6 inhibitor) is an approved drug for BC treatment. However, the drug resistance and metastasis can impair the treatment outcome of Palbociclib. Understanding the mechanisms of EMT and Palbociclib drug resistance in BC is conducive to the formulation of novel therapeutic strategy. Here, we investigated the role of circHIAT1/miR-19a-3p/CADM2 axis in modulating EMT and Palbociclib resistance in BC. circHIAT1 and CADM2 were down-regulated in BC tissues and cell lines, and miR-19a-3p showed an up-regulation. circHIAT1 could interact with miR-19a-3p and suppress its activity, while miR-19a-3p functioned to negatively regulate CADM2. Forced over-expression of circHIAT1 could impaired the EMT status and migratory ability of BC cells, and this effect was inhibited by miR-19a-3p mimic. In addition, we also generated Palbociclib resistant BC cells, and showed that circHIAT1 and CADM2 were down-regulated in the resistant BC cells while miR-19a-3p showed an up-regulation. Forced circHIAT1 over-expression re-sensitized BC cells to Palbociclib treatment. Quercetin, a bioactive flavonoid, could suppressed the migration and invasion of BC cells, and re-sensitized BC cells to Palbociclib. The anti-cancer effect of quercetin could be attributed to its regulatory effect on circHIAT1/miR-19a-3p/CADM2 axis. In vivo tumorigenesis experiment further revealed that quercetin administration enhanced the anti-cancer effect of Palbociclib, an effect was dependent on the up-regulation of circHIAT1 by quercetin. In summary, this study identified quercetin as a potential anti-cancer compound to reverse Palbociclib resistance and impair EMT in BC cells by targeting circHIAT1/miR-19a-3p/CADM2 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionMicroRNAsBreast NeoplasmsDrug Resistance, NeoplasmPyridinesPiperazinesQuercetinCyclin-Dependent Kinase 6HumansFemaleCell Line, TumorAnimalsMiceGene Expression Regulation, NeoplasticCyclin-Dependent Kinase 4Cell MovementRNA, Long NoncodingMice, NudeXenograft Model Antitumor Assays

Substanzen

MicroRNAspalbociclibPyridinesPiperazinesQuercetinMIRN19A microRNA, humanCyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4RNA, Long NoncodingCDK6 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.

ORCID-Profile: Bo Li

Förderung

  • the Medical Reserve Talent Program of Yunnan Provincial Health Commission
  • Scientific Research Fund Project of Education Department of Yunnan Province

Zitieren

APA

Li, X., Niu, C., Yi, G., Zhang, Y., Jin, W., Zhang, Z., Zhang, W., & Li, B. (2024). Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis. PLOS ONE. https://doi.org/10.1371/journal.pone.0305612

Vancouver

Li X, Niu C, Yi G, Zhang Y, Jin W, Zhang Z, et al. Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis. PLOS ONE. 2024. doi:10.1371/journal.pone.0305612

BibTeX
@article{Li2024,
  author = {Li, Xiaogang and Niu, Chao and Yi, Guoqiang and Zhang, Yuan and Jin, Wendi and Zhang, Zhiping and Zhang, Wanfu and Li, Bo},
  title = {Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0305612}
}
Kostenlos starten →